Avoro Capital Advisors LLC grew its holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 15.6% during the 4th quarter, HoldingsChannel reports. The firm owned 5,666,666 shares of the biopharmaceutical company’s stock after acquiring an additional 766,666 shares during the quarter. Xenon Pharmaceuticals comprises about 3.6% of Avoro Capital Advisors LLC’s investment portfolio, making […]
Westfield Capital Management Co. LP acquired a new position in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 237,495 shares of the biopharmaceutical company’s stock, valued at approximately $10,939,000. Westfield Capital Management Co. […]
Westfield Capital Management Co. LP bought a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 237,495 shares of the biopharmaceutical company’s stock, valued at approximately $10,939,000. A number of […]
China Universal Asset Management Co. Ltd. boosted its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 417.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,546 shares of the biopharmaceutical company’s stock after buying an additional […]
SG Americas Securities LLC reduced its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 67.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,606 shares of the biopharmaceutical company’s stock after selling 38,146 shares during the quarter. SG […]